If the United States were to implement a strategy in Cuba similar to the one proposed for Venezuela—comprising phases of ...
Abstract: To mitigate the Doppler fading that arises in high-mobility communication systems and improve channel capacity, it is essential to develop innovative methods for flexibly manipulating the ...
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026 ...
A new probeless smart oven uses cameras and weight sensors to identify the precise geometry of the food you stick inside.
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...
China NMPA grants marketing approval for ArkBio’s Azstarys for the treatment of ADHD: Shanghai, China Wednesday, January 7, 2026, 16:00 Hrs [IST] Shanghai Ark Biopharmaceutical ...
Trump chose to work with a sanctioned regime insider accused of human rights abuses and cartel ties rather than the elected ...
A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...
The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
Ketamine's rapid antidepressant effects have led to a significant increase in off-label psychiatric use, despite the lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results